vs
科睿唯安（CLVT）与Everus Construction Group, Inc.（ECG）财务数据对比。点击上方公司名可切换其他公司
Everus Construction Group, Inc.的季度营收约是科睿唯安的1.6倍（$1.0B vs $617.0M），Everus Construction Group, Inc.净利率更高（5.5% vs 0.5%，领先5.0%），Everus Construction Group, Inc.同比增速更快（33.2% vs -6.9%），科睿唯安自由现金流更多（$89.2M vs $23.5M），过去两年Everus Construction Group, Inc.的营收复合增速更高（27.1% vs -0.3%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
CLVT vs ECG — 直观对比
营收规模更大
ECG
是对方的1.6倍
$617.0M
营收增速更快
ECG
高出40.1%
-6.9%
净利率更高
ECG
高出5.0%
0.5%
自由现金流更多
CLVT
多$65.7M
$23.5M
两年增速更快
ECG
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $617.0M | $1.0B |
| 净利润 | $3.1M | $55.3M |
| 毛利率 | 66.8% | 11.6% |
| 营业利润率 | 6.7% | 6.8% |
| 净利率 | 0.5% | 5.5% |
| 营收同比 | -6.9% | 33.2% |
| 净利润同比 | 101.6% | 60.4% |
| 每股收益（稀释后） | $0.00 | $1.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTECG
| Q4 25 | $617.0M | $1.0B | ||
| Q3 25 | $623.1M | $986.8M | ||
| Q2 25 | $621.4M | $921.5M | ||
| Q1 25 | $593.7M | $826.6M | ||
| Q4 24 | $663.0M | $759.6M | ||
| Q3 24 | $622.2M | $761.0M | ||
| Q2 24 | $650.3M | $703.4M | ||
| Q1 24 | $621.2M | $625.7M |
净利润CLVTECG
| Q4 25 | $3.1M | $55.3M | ||
| Q3 25 | $-28.3M | $57.0M | ||
| Q2 25 | $-72.0M | $52.8M | ||
| Q1 25 | $-103.9M | $36.7M | ||
| Q4 24 | $-191.8M | $34.5M | ||
| Q3 24 | $-65.6M | $41.8M | ||
| Q2 24 | $-304.3M | $39.0M | ||
| Q1 24 | $-75.0M | $28.2M |
毛利率CLVTECG
| Q4 25 | 66.8% | 11.6% | ||
| Q3 25 | 65.0% | 12.6% | ||
| Q2 25 | 67.2% | 13.0% | ||
| Q1 25 | 65.1% | 11.2% | ||
| Q4 24 | 65.7% | 11.4% | ||
| Q3 24 | 66.2% | 11.8% | ||
| Q2 24 | 67.2% | 12.6% | ||
| Q1 24 | 64.9% | 11.9% |
营业利润率CLVTECG
| Q4 25 | 6.7% | 6.8% | ||
| Q3 25 | 7.1% | 7.3% | ||
| Q2 25 | 1.1% | 7.9% | ||
| Q1 25 | -3.5% | 6.2% | ||
| Q4 24 | -9.4% | 6.1% | ||
| Q3 24 | 3.5% | 7.1% | ||
| Q2 24 | -36.9% | 7.3% | ||
| Q1 24 | 0.8% | 6.2% |
净利率CLVTECG
| Q4 25 | 0.5% | 5.5% | ||
| Q3 25 | -4.5% | 5.8% | ||
| Q2 25 | -11.6% | 5.7% | ||
| Q1 25 | -17.5% | 4.4% | ||
| Q4 24 | -28.9% | 4.5% | ||
| Q3 24 | -10.5% | 5.5% | ||
| Q2 24 | -46.8% | 5.5% | ||
| Q1 24 | -12.1% | 4.5% |
每股收益（稀释后）CLVTECG
| Q4 25 | $0.00 | $1.09 | ||
| Q3 25 | $-0.04 | $1.11 | ||
| Q2 25 | $-0.11 | $1.03 | ||
| Q1 25 | $-0.15 | $0.72 | ||
| Q4 24 | $-0.27 | $0.68 | ||
| Q3 24 | $-0.09 | $0.82 | ||
| Q2 24 | $-0.46 | $0.76 | ||
| Q1 24 | $-0.14 | $0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | — |
| 总债务越低越好 | $4.3B | $281.5M |
| 股东权益账面价值 | $4.8B | $629.8M |
| 总资产 | $11.1B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.89× | 0.45× |
8季度趋势，按日历期对齐
现金及短期投资CLVTECG
| Q4 25 | $329.2M | — | ||
| Q3 25 | $318.7M | — | ||
| Q2 25 | $362.6M | — | ||
| Q1 25 | $354.0M | — | ||
| Q4 24 | $295.2M | — | ||
| Q3 24 | $388.5M | $553.0K | ||
| Q2 24 | $376.4M | — | ||
| Q1 24 | $361.8M | — |
总债务CLVTECG
| Q4 25 | $4.3B | $281.5M | ||
| Q3 25 | $4.4B | $285.1M | ||
| Q2 25 | $4.5B | $288.6M | ||
| Q1 25 | $4.5B | $292.1M | ||
| Q4 24 | $4.5B | $295.6M | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — | ||
| Q1 24 | $4.6B | — |
股东权益CLVTECG
| Q4 25 | $4.8B | $629.8M | ||
| Q3 25 | $4.9B | $573.0M | ||
| Q2 25 | $5.0B | $514.4M | ||
| Q1 25 | $5.0B | $460.2M | ||
| Q4 24 | $5.1B | $422.6M | ||
| Q3 24 | $5.5B | $453.3M | ||
| Q2 24 | $5.6B | $490.0M | ||
| Q1 24 | $5.9B | $464.3M |
总资产CLVTECG
| Q4 25 | $11.1B | $1.7B | ||
| Q3 25 | $11.2B | $1.6B | ||
| Q2 25 | $11.4B | $1.5B | ||
| Q1 25 | $11.5B | $1.4B | ||
| Q4 24 | $11.5B | $1.3B | ||
| Q3 24 | $12.0B | $1.3B | ||
| Q2 24 | $12.1B | — | ||
| Q1 24 | $12.5B | — |
负债/权益比CLVTECG
| Q4 25 | 0.89× | 0.45× | ||
| Q3 25 | 0.90× | 0.50× | ||
| Q2 25 | 0.90× | 0.56× | ||
| Q1 25 | 0.90× | 0.63× | ||
| Q4 24 | 0.88× | 0.70× | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.9M | $48.2M |
| 自由现金流经营现金流 - 资本支出 | $89.2M | $23.5M |
| 自由现金流率自由现金流/营收 | 14.5% | 2.3% |
| 资本支出强度资本支出/营收 | 11.5% | 2.4% |
| 现金转化率经营现金流/净利润 | 51.58× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $365.3M | $90.0M |
8季度趋势，按日历期对齐
经营现金流CLVTECG
| Q4 25 | $159.9M | $48.2M | ||
| Q3 25 | $181.1M | $76.2M | ||
| Q2 25 | $116.3M | $25.3M | ||
| Q1 25 | $171.2M | $7.1M | ||
| Q4 24 | $141.3M | — | ||
| Q3 24 | $202.9M | $78.9M | ||
| Q2 24 | $126.2M | — | ||
| Q1 24 | $176.2M | $21.9M |
自由现金流CLVTECG
| Q4 25 | $89.2M | $23.5M | ||
| Q3 25 | $115.5M | $65.7M | ||
| Q2 25 | $50.3M | $12.3M | ||
| Q1 25 | $110.3M | $-11.4M | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $126.3M | $60.9M | ||
| Q2 24 | $60.3M | — | ||
| Q1 24 | $111.8M | $12.6M |
自由现金流率CLVTECG
| Q4 25 | 14.5% | 2.3% | ||
| Q3 25 | 18.5% | 6.7% | ||
| Q2 25 | 8.1% | 1.3% | ||
| Q1 25 | 18.6% | -1.4% | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 20.3% | 8.0% | ||
| Q2 24 | 9.3% | — | ||
| Q1 24 | 18.0% | 2.0% |
资本支出强度CLVTECG
| Q4 25 | 11.5% | 2.4% | ||
| Q3 25 | 10.5% | 1.1% | ||
| Q2 25 | 10.6% | 1.4% | ||
| Q1 25 | 10.3% | 2.2% | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 12.3% | 2.4% | ||
| Q2 24 | 10.1% | — | ||
| Q1 24 | 10.4% | 1.5% |
现金转化率CLVTECG
| Q4 25 | 51.58× | 0.87× | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.89× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
